Researchers investigate the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma

FHS
July 31, 2023
11:59 am

Researchers investigated the efficacy of a novel intra-tumoral drug delivery carrier in treating oral squamous cell carcinoma.

Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard

October 21, 2024

Nutritional interventions for type 2 diabetes management with glycemic control

Researchers explore the effects of healthy diet interventions on various body mass and cardiometabolic parameters.

May 6, 2024

EU Allocates €6.5M for Psychedelic Study

The TDR Three Key Takeaways: 1. The EU €6.5 million investment in the PsyPal trial marks its first foray into funding psychedelic therapy research, aiming

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.